CGRP Forum is made possible thanks to support from AbbVie, Lilly, Organon and Pfizer, all of whom have no influence or control of editorial content. More information is available here »

Latest:

Positive data reported for eptinezumab in Sunrise trial New insights on treatment holidays with erenumab Dual CGRP ligand mAb and gepant therapy reduces headache severity CGRP-mAb switching yields migraine day reduction Lower switching rates with atogepant than CGRP mAbs EMBRACE shows erenumab reduces migraine severity Older patients benefit from CGRP mAbs too DELIVER shows long term QoL benefits with eptinezumab

Dr Delphine Magis MD, PhD

Editorial Board

Neurologist & Head of Headache Research Unit

University Department of Neurology, CHR Hospital, Liege, Belgium

Dr Delphine Magis is a Neurologist and heads the Headache Research Unit at the University Department of Neurology, CHR Hospital, Liege, Belgium. She authored or co-authored more than a hundred articles, book chapters or abstracts in the field of Headache.

Her areas of expertise are headache electrophysiology, emerging therapies, and neuromodulation. She took/is taking part to several international clinical studies using CGRP antibodies in migraine and cluster headache treatment. She is co-chair of the International Headache Society’s special interest group on emerging therapies and member of the board of the IHS education subcommittee.

« Back to Editorial Board

Educational Partners and Supporters

This program is funded in part via an independent educational grant from AbbVie.

Organon has provided sponsorship towards this independent resource. Organon has had no editorial input or control over content, nor opportunity to influence.

Financial support was provided as GMG Knowledge Gap Grant from Pfizer Inc, Pfizer have provided only financial support and had no input into the content provided.

Editorial PolicyCGRP Forum is an expert resource for clinicians and healthcare professionals working with migraine patients. All patients should discuss their medication with their healthcare professional. Unless otherwise indicated, opinions expressed in the CGRP Education and Research Forum are those of the contributors. Although every effort is made to ensure accuracy and avoid mistakes, no liability on the part of the CGRP Forum, the editors or the editorial board is accepted for the consequences of any misleading or inaccurate information.

Dr Delphine Magis MD, PhD

Disclosures

Articles by Delphine Magis